Aquestive Therapeutics (AQST) EPS (Weighted Average and Diluted): 2020-2025
Historic EPS (Weighted Average and Diluted) for Aquestive Therapeutics (AQST) over the last 6 years, with Sep 2025 value amounting to -$0.14.
- Aquestive Therapeutics' EPS (Weighted Average and Diluted) fell 7.69% to -$0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.71, marking a year-over-year decrease of 54.35%. This contributed to the annual value of -$0.51 for FY2024, which is 292.31% down from last year.
- Latest data reveals that Aquestive Therapeutics reported EPS (Weighted Average and Diluted) of -$0.14 as of Q3 2025, which was down 0.00% from -$0.14 recorded in Q2 2025.
- In the past 5 years, Aquestive Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $0.11 in Q1 2023 and a low of -$0.73 during Q4 2021.
- In the last 3 years, Aquestive Therapeutics' EPS (Weighted Average and Diluted) had a median value of -$0.13 in 2024 and averaged -$0.11.
- Per our database at Business Quant, Aquestive Therapeutics' EPS (Weighted Average and Diluted) plummeted by 371.43% in 2021 and then surged by 134.38% in 2023.
- Aquestive Therapeutics' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.73 in 2021, then spiked by 69.86% to -$0.22 in 2022, then soared by 40.91% to -$0.13 in 2023, then plummeted by 46.15% to -$0.19 in 2024, then declined by 7.69% to -$0.14 in 2025.
- Its last three reported values are -$0.14 in Q3 2025, -$0.14 for Q2 2025, and -$0.24 during Q1 2025.